Hazard for prostate cancer-specific mortality after radical prostatectomy

A new analysis of information from the Surveillance, Epidemiology and End Results (SEER) database suggests that the “hazard” for prostate cancer-specific mortality after radical prostatectomy is very low but that it does increase in a continuous manner for at least 15 years post-treatment. … READ MORE …

Projection of 15-year prostate cancer-specific survival after radical prostatectomy

For several years we have been able to use the Kattan nomograms to project 5-, 7-, and 10-year recurrence-free survival before and after radical prostatectomy for localized prostate cancer, based on the patient’s age, stage, Gleason score, and other relevant data (associated with biopsy or surgical findings, as appropriate). … READ MORE …

A 45 percent reduction in prostate cancer-specific mortality? Not exactly.

According to a report yesterday in Consumer Affairs, “American men with prostate cancer were 45 percent less likely to die from the disease in 2006 than they were in 1999.” … READ MORE …

Comorbidities and risk for prostate cancer-specific mortality

It is not exactly news that men who are diagnosed with localized prostate cancer, but who have a significant number of comorbid conditions, are actually at relatively low risk of prostate cancer-specific mortality. … READ MORE …

Positive surgical margins and prostate cancer-specific mortality

An article in the June issue of the Journal of Urology has suggested a definitive link between positive surgical margins (PSMs) post-surgery and prostate cancer-specific mortality (PCSM). … READ MORE …

15-year outcomes after radical prostatectomy: a new predictive model

An article just published by a highly respected group of specialists in the Journal of Clinical Oncology adds emphasis to the problem faced by patients newly diagnosed with low- or intermediate-risk localized prostate cancer. … READ MORE …